ALTA SKELTON: Open Payments
NPI 1457456659 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 11 payments from 7 companies in 2025. Trend: 2023 $219 · 2024 $487 · 2025 $198
Food & beverage: $198
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 2 | $45 |
| Acella Pharmaceuticals, LLC | 2 | $39 |
| Novo Nordisk Inc | 2 | $35 |
| ABBVIE INC. | 2 | $33 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| PFIZER INC. | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: Korlym, NP Thyroid 60, Ozempic, UBRELVY, CONTRAVE, VRAYLAR, NURTEC ODT, XIFAXAN.
Industry payments across IN — which companies pay providers there.
